GBIO PE Ratio & Valuation,Is GBIO Overvalued

GBIO Relative Valuation

GBIO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GBIO is overvalued; if below, it's undervalued.

Historical Valuation

Generation Bio Co (GBIO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -4.02. The fair price of Generation Bio Co (GBIO) is between NaN to NaN according to relative valuation methord.

Relative Value

Fair Zone

NaN-NaN

Current Price：5.39

Fair

-0.74

0.00

EV/EBITDA

Generation Bio Co. (GBIO) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is -0.81. The thresholds are as follows: Strongly Undervalued below -7.46, Undervalued between -7.46 and -4.13, Fairly Valued between 2.52 and -4.13, Overvalued between 2.52 and 5.84, and Strongly Overvalued above 5.84. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.38

EV/EBIT

Generation Bio Co. (GBIO) has a current EV/EBIT of 0.38. The 5-year average EV/EBIT is -2.03. The thresholds are as follows: Strongly Undervalued below -10.20, Undervalued between -10.20 and -6.12, Fairly Valued between 2.05 and -6.12, Overvalued between 2.05 and 6.13, and Strongly Overvalued above 6.13. The current Forward EV/EBIT of 0.38 falls within the Historic Trend Line -Fairly Valued range.

56.29

Generation Bio Co. (GBIO) has a current PS of 56.29. The 5-year average PS is 99.34. The thresholds are as follows: Strongly Undervalued below -216.92, Undervalued between -216.92 and -58.79, Fairly Valued between 257.47 and -58.79, Overvalued between 257.47 and 415.60, and Strongly Overvalued above 415.60. The current Forward PS of 56.29 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Generation Bio Co. (GBIO) has a current P/OCF of 0.00. The 5-year average P/OCF is -77.40. The thresholds are as follows: Strongly Undervalued below -713.31, Undervalued between -713.31 and -395.36, Fairly Valued between 240.55 and -395.36, Overvalued between 240.55 and 558.51, and Strongly Overvalued above 558.51. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

Generation Bio Co. (GBIO) has a current P/FCF of 0.00. The 5-year average P/FCF is 41.18. The thresholds are as follows: Strongly Undervalued below -320.20, Undervalued between -320.20 and -139.51, Fairly Valued between 221.87 and -139.51, Overvalued between 221.87 and 402.55, and Strongly Overvalued above 402.55. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Generation Bio Co (GBIO) has a current Price-to-Book (P/B) ratio of 0.72. Compared to its 3-year average P/B ratio of 0.92 , the current P/B ratio is approximately -22.18% higher. Relative to its 5-year average P/B ratio of 1.53, the current P/B ratio is about -53.04% higher. Generation Bio Co (GBIO) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -120.03%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -78.94% , the current FCF yield is about -100.00% lower.

0.72

P/B

Median3y

0.92

Median5y

1.53

-313.60

FCF Yield

Median3y

-120.03

Median5y

-78.94

Competitors Valuation Multiple

The average P/S ratio for GBIO's competitors is 0.00, providing a benchmark for relative valuation. Generation Bio Co Corp (GBIO) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -78.90%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of GBIO decreased by 49.15% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -202.71 to -346.30.

The secondary factor is the P/E Change, contributed -41.09%to the performance.

Overall, the performance of GBIO in the past 1 year is driven by Margin Expansion. Which is more sustainable.

-78.90%

7.55M → 1.59M

Revenue Growth

70.84%

-202.71 → -346.30

Margin Expansion

-41.09%

-0.98 → -0.58

P/E Change

-49.15%

10.60 → 5.39

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Generation Bio Co (GBIO) currently overvalued or undervalued?

What is Generation Bio Co (GBIO) fair value?

GBIO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Generation Bio Co (GBIO) is between NaN to NaN according to relative valuation methord.

How does GBIO's valuation metrics compare to the industry average?

What is the current P/B ratio for Generation Bio Co (GBIO) as of Dec 16 2025?

As of Dec 16 2025, Generation Bio Co (GBIO) has a P/B ratio of 0.72. This indicates that the market values GBIO at 0.72 times its book value.

What is the current FCF Yield for Generation Bio Co (GBIO) as of Dec 16 2025?

As of Dec 16 2025, Generation Bio Co (GBIO) has a FCF Yield of 0.00%. This means that for every dollar of Generation Bio Co’s market capitalization, the company generates 0.00 cents in free cash flow.

What is the current Forward P/E ratio for Generation Bio Co (GBIO) as of Dec 16 2025?

As of Dec 16 2025, Generation Bio Co (GBIO) has a Forward P/E ratio of -0.74. This means the market is willing to pay $-0.74 for every dollar of Generation Bio Co’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Generation Bio Co (GBIO) as of Dec 16 2025?

As of Dec 16 2025, Generation Bio Co (GBIO) has a Forward P/S ratio of 0.00. This means the market is valuing GBIO at $0.00 for every dollar of expected revenue over the next 12 months.

GBIO Valuation

GBIO Valuation

GBIO Relative Valuation

Historical Valuation

Competitors Valuation Multiple

Performance Decomposition

People Also Watch

Frequently Asked Questions

Is Generation Bio Co (GBIO) currently overvalued or undervalued?

What is Generation Bio Co (GBIO) fair value?

How does GBIO's valuation metrics compare to the industry average?

What is the current P/B ratio for Generation Bio Co (GBIO) as of Dec 16 2025?

What is the current FCF Yield for Generation Bio Co (GBIO) as of Dec 16 2025?

What is the current Forward P/E ratio for Generation Bio Co (GBIO) as of Dec 16 2025?

What is the current Forward P/S ratio for Generation Bio Co (GBIO) as of Dec 16 2025?